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Summary optic neuropathy (LHON) (Bolhuis et al. 1990; Lott et
al. 1990; Newman et al. 1991) or the nt 8993 (TrG)
Rapid changes in mtDNA variants between generations mutation (Tulinius et al. 1995; de Coo et al. 1996). To
have led to the bottleneck theory, which proposes a explain this rapid shift, it has been suggested that at
dramatic reduction in mtDNA numbers during early oo- some stage in oogenesis the number of mitochondrial
genesis. We studied oocytes from a woman with hetero- genomes within any one developing oocyte is reduced
plasmic expression of the mtDNA nt 8993 (TrG) muta- to as few as ﬁve or less (Hauswirth and Laipis 1982,
tion. Of seven oocytes analyzed, one showed no evidence 1985; Laipis et al. 1988; Ashley et al. 1989; Koehler et
of the mutation, and the remaining six had a mutant al. 1991). Thus, with subsequent generations, some of
load ú95%. This skewed expression of the mutation in the progeny of these oocytes may be either homoplasmic
oocytes is not compatible with the conventional bottle- for the wild-type DNA or homoplasmic for the mtDNA
neck theory. A possible explanation is that, during am- variant.
pliﬁcation of mtDNA in the developing oocyte, mtDNA Maintenance of a heteroplasmic silent mtDNA poly-
from one mitochondrion is preferentially ampliﬁed. morphism in a multigeneration family with a homoplas-
Thus, subsequent mature oocytes may contain predomi- mic LHON mtDNA mutation has been reported else-
nantly wild-type or mutant mitochondrial genomes. where (Howell et al. 1992). That study concluded that
the number of mtDNA genomes at the bottleneck was
36–2,400, suggesting that mitochondrial gene segrega-Introduction
tion was more complex than predicted by the bottleneck
mtDNA has a high mutation rate, Ç10 times greater theory.
than that of the nuclear genome. Individual cells contain The studies cited above are based on genetic analysis
several thousand copies of mtDNA, and, in normal indi- of mtDNA in white blood cells. It is becoming apparent,
viduals, nearly all of the mtDNA is thought to be identi- however, that the distribution of mtDNA variants in
cal (a state termed ‘‘homoplasmy’’) and of maternal ori- tissues is inﬂuenced by a number of factors and that the
gin. However, in some cases, especially in mitochondrial level of a mtDNA variant in blood does not always
disease, wild-type and variant mtDNA coexist at differ- predict the distribution of the variant in other tissues
ent levels (a state termed ‘‘heteroplasmy’’; DiMauro (Holt et al. 1989; Poulton and Morten 1993). Thus, to
1993; Shoffner and Wallace 1995). understand the mechanisms that determine mtDNA
It might be expected that a large number of genera- variation during oogenesis, it is important to study
tions would be necessary for a mutation or polymor- oocytes.
phism that arose in one generation to increase such that We have analyzed mtDNA in oocytes from the asymp-
it would represent a substantial proportion of cellular tomatic mother of three children with heteroplasmic ex-
mtDNA. However, rapid shifts in mtDNA variant fre- pression of the mtDNA nt 8993 (TrG) mutation associ-
quency have been observed in Holstein cows and also in ated with Leigh syndrome (Shoffner et al. 1992; Tatuch
human maternal pedigrees with either Leber hereditary et al. 1992). Individual oocytes contained either very
high or undetectable levels of mutant mtDNA mole-
cules.We suggest that this may reﬂect preferential ampli-
ﬁcation of an mtDNA variant during oogenesis, and weReceived September 25, 1995; accepted for publication March 13,
1997. discuss our results in light of the bottleneck theory.
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en’s Hospital ethics committee, and informed consent follows that of Anderson et al. (1981). The nt 8993
(TrG) substitution introduces a novel HpaII restrictionwas obtained from all patients in this study. Control
oocytes were donated by patients undergoing in vitro site at nt 8993, which is identiﬁed after digestion of the
PCR product described above. PCR ampliﬁcations werefertilization at the Royal Women’s Hospital.
Ovarian stimulation regimens have been reported performed for 35 cycles of 95C for 1 min, 56C for 1
min, and 72C for 2 min. Ten-microliter aliquots of theelsewhere (Gook et al. 1994). Oocyte maturation was
triggered by an injection of human chorionic gonadotro- PCR reactions were digested in a total reaction volume
of 20 ml containing 20 units of restriction endonucleasephin (HCG; 10,000 IU; Profasi; Serono) administered
when three follicles ú18 mm were detected on ultra- HpaII, at 37C for 3 h. The samples were electropho-
resed through a 3.0% [w/v] NuSieve agarose gel con-sound. Eight oocyte-cumulus complexes were retrieved
transvaginally under ultrasound guidance 36 h after taining ethidium bromide. PCR products were visualized
by use of a 320-nm UV transilluminator.HCG administration. Oocyte-cumulus complexes were
transferred to Earles balanced salt solution supple- 3. PCR from Guthrie blood spots.—To each of the
eluted samples was added 10 ml of 2 mM dNTPs, 1 mlmented with synthetic serum replacement, pyruvate, and
1% (w/v) human serum albumin (Medicult). At no time of primer 8961F (1 mg/ml stock), 1 ml of primer 9050R
(1 mg/ml stock), and 0.5 ml of Taq polymerase (5were these oocytes exposed to sperm.
Individual oocytes were prepared, frozen, and thawed U/ml). PCR ampliﬁcations were performed for 35 cycles
of 95C for 1 min, 56C for 1 min, and 72C for 2 min).as described elsewhere (Gook et al. 1993). Complete
removal of cumulus and corona cells from the oocytes HpaII restriction digests were performed as described
above.was achieved by brief exposure to hyaluronidase (50
IU/ml), followed by mechanical disruption. The zona 4. Radioactive (quantitative) PCR.—Either Ç20 ng of
total DNA or 2 ml of the ﬁrst-round whole-genome am-pellucida was partially or completely removed by diges-
tion with 0.125% (w/v) pronase (Boehringer Mann- pliﬁcation of the oocytes was ampliﬁed in a standard
50-ml PCR with the mtDNA primer set 8961F andheim) in 4-(2-hydroxyethyl)-1-piperazine ethane sul-
fonic acid–buffered human tubular ﬂuid medium 9050R. After 24 cycles of 95C for 1 min, 56C for 1
min, and 72C for 2 min, 10 mCi of a32P-dCTP was(Irvine) supplemented with 20% (v/v) serum substitute
(Irvine). added to each sample during the denaturation step of
the ﬁnal cycle: 95C for 3 min, 56C for 1 min, and
DNA Extraction 72C for 2 min.
Endonuclease HpaII digestion was as describedTotal DNA was extracted from whole blood, cultured
skin ﬁbroblasts, tissue samples, and Guthrie blood spots, above. The products were analyzed after electrophore-
sis through a 15% nondenaturing polyacrylamide gel.as described elsewhere (Blok et al. 1995b).
The dried gel was exposed to x-ray ﬁlm at room tem-
PCR Studies perature, and the relative proportions of wild-type and
mutant DNA were estimated after densitometry of the1. Total genome ampliﬁcation.—Pronase-treated oo-
cytes (or 1 drop of pronase solution) were placed into autoradiogram by use of a Bio-Rad imaging densitom-
eter (model GS-670).20 ml of sterile distilled water and stored at 020C until
required. Prior to PCR analysis, the samples were incu- To conﬁrm complete HpaII digestion, the primer set
3130F (5 3130–3149 3) and 3558R (5 3558–3539bated at 95C for 15 min to lyse the oocytes. Total
genome ampliﬁcation was performed in a total volume 3) was included in the PCR described above. This
primer set ampliﬁes the region of the mitochondrial ge-of 50 ml, as described elsewhere (Schmitt et al. 1994),
by use of a thermal cycler (model FTS-320; Corbett Re- nome either side of the HpaII restriction site at nt 3246.
Multiplex PCR products were digested with HpaII andsearch), with conditions of 95C for 3 min; 49 cycles of
95C for 1 min, 37C for 2 min, and 55C for 4 min; were analyzed as described above.
To determine the reproducibility of mtDNA mutant-and 1 cycle of 95C for 1 min, 37C for 2 min, and 72C
for 7 min. load estimations from single oocytes, we performed PCR
analysis on four samples of patient DNA (isolated from2. Gene-speciﬁc PCR.—Either 2 ml of the ﬁrst-round
PCR described above or 20 ng of total DNA extracted blood), with different loads of the nt 8993 (TrG) muta-
tion. The mutant load was determined by six indepen-from patient or control samples was used in a total
reaction volume of 50 ml, for mtDNA gene-speciﬁc am- dent whole-genome ampliﬁcations of 350, 35, 3.5, and
0.35 pg of lymphocyte DNA of each sample, followedpliﬁcation. Reactions were as described above, except
that, in place of the random 15mer primers, the mtDNA- by radioactive gene-speciﬁc PCR analysis as described
above. However, the number of PCR cycles was in-speciﬁc primer set used was 8961F (5 8961–8980 3)
and 9050R (5 9050–9031 3), each at a concentration creased to 32, and the intensity of radioactive mutant
and wild-type HpaII bands was determined on a Molec-of 10 mg/ml. Numbering of mtDNA nucleotide positions
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ular Dynamics Phosphorimager. The mutant load of available. This suggests that the mutation either arose in
individual III-1’s mother or resulted from a spontaneouseach sample was also estimated by direct gene-speciﬁc
PCR analysis (without whole-genome ampliﬁcation) of mutagenic event during embryogenesis in III-1 (ﬁg. 1).
20 ng of DNA samples.
Skewed Expression of the mtDNA nt 8993 (TrG)5. DNA sequence analysis.—PCR-ampliﬁed DNA
Mutation in Oocyteswas sequenced as described elsewhere (Blok et al.
1995a). The mtDNA D-loop region was ampliﬁed by After genetic counseling, III-1 decided to have a tubal
ligation to prevent any subsequent pregnancies. At heruse of primer set 15981F (5 15981–16000 3) and 57R
(5 57–38 3) and primer set 16541F (5 16541–16560 request, and after informed consent was obtained, her
ovaries were hyperstimulated, and eight oocytes were3) and 630R (5 630–611 3). The DNAs were se-
quenced by use of the same primers plus primer set 420R harvested for analysis of the mtDNA mutation. Seven
of the eight oocytes gave a result when analyzed for the(5 420–401 3) and 16400F (5 16400–16419 3).
nt 8993 (TrG) mutation (ﬁg. 2). One oocyte (number
1) had only normal mtDNA, six oocytes (numbers 2–Results
7) had a mutant load ú95% (ﬁg. 2), and one oocyteMaternal Transmission of the mtDNA nt 8993 (TrG)
(number 8) failed to yield an identiﬁable PCR gene prod-Mutation
uct, suggesting that this oocyte was probably not recov-
We identiﬁed the nt 8993 (TrG) mutation in two ered after the pronase-treatment step. It is possible that
male siblings with Leigh syndrome (IV-3 and IV-1; ﬁg. the oocyte (number 1) that did not have a detectable
1 [patient 23 and sibling, respectively, in Rahman et al. load of the nt 8993 (TrG) mutation may have contained
1996]), a third male sibling who died at 3 mo of age the mutation at a level below the sensitivity of detection
with a diagnosis of sudden infant death syndrome (SIDS) in our study. Control oocytes from an unrelated female
(IV-2; ﬁg. 1), and the asymptomatic mother (III-1; ﬁg. were also negative for the mutation. Aliquots of ﬁrst-
1). The mother has a mutant load of 50% in her blood, round no-DNA negative controls were included in the
consistent with both her being a carrier of the patho- second-round mtDNA-speciﬁc PCR. These and second-
genic mtDNA point mutation and her lack of symptoms. round negative (no DNA) controls did not yield a PCR
Generally, expression of the nt 8993 (TrG) mutation product, suggesting the absence of contaminating
at a level ú70% is required for clinical symptoms (San- mtDNA in the reactions (ﬁg. 2, lanes pri-1 and pri-2).
torelli et al. 1993; Shoffner and Wallace 1995). In con- To conﬁrm that the low levels of wild-type mtDNA
trast, the three progeny of this woman had levelsú85% that we consistently observed in oocytes containing the
in tissues analyzed. The mutation was not detected in mutation were not artifacts due to incomplete digestion,
blood from other maternal relatives, when such was multiplex PCRs were performed, in which the second-
round PCR described above included primers for ampli-
ﬁcation of a nonrelated mtDNA gene product with a
single homoplasmic HpaII site. The control HpaII site
was cleaved to completion under conditions in which
the mtDNA in the oocytes was not (data not shown).
Sequence analysis of the mtDNA nt 8993 region in oo-
cyte 1 showed a wild-type sequence, making it unlikely
that the absence of a HpaII site is due to a second muta-
tion introduced during PCR ampliﬁcation.
To ensure that there was not preferential ampliﬁca-
tion of one of the mtDNA variants, an aliquot of ﬁrst-
round whole genome–ampliﬁcation PCR, from oocyte
1, was mixed with that of mutation-containing oocytes
prior to the mtDNA-speciﬁc PCR. The presence of both
mtDNA variants in the second-round PCR did not in-
ﬂuence the efﬁciency of ampliﬁcation of both sequence
variants (ﬁg. 3). We also performed whole-genome and
Figure 1 Familial expression of the nt 8993 (TrG) mtDNA gene-speciﬁc ampliﬁcation on DNA from four samples
mutation. When available, mtDNA from blood (Bl), muscle (Mu), or containing various proportions of the nt 8993 (TrG)
ﬁbroblasts (Fb) from indicated symptomatic members (Leigh syn- mutation. Assuming that a lymphocyte contains 7 pg of
drome [LS] and sudden infant-death syndrome [SIDS]) and asymptom-
total DNA and has Ç2,000 mtDNA copies (Vaillantatic members of the pedigree was analyzed, by PCR, for presence
and Nagley 1995), we calculate that 350 pg of lympho-of the nt 8993 (TrG) mutation. Mutant loads, which are shown in
parentheses, were estimated after radioactive PCR and densitometry. cyte DNA contains 100,000 mtDNA molecules, equiva-
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cies would be unlikely even if 99.9% of the mtDNA
content of a single oocyte had been accidentally lost.
We sequenced the mtDNA D-loop region (a 1,119-
bp fragment spanning nt 16031–580) of maternal blood
and oocyte 1 and conﬁrmed, on the basis of the identity
of the DNA sequences, that the DNA in oocyte 1 was
maternally derived and not due to external contamina-
tion. Both sequences differed from that reported by An-
derson et al. (1981), at nt 263 (TrG) and at nt 303–
309 (eight C’s) and 311–315 (six C’s). This D-loop
sequence was not among 52 D-loop groups determined
in 525 individuals, including 142 Caucasians (Stoneking
et al. 1991). On the basis of the frequencies of D-loop
variations, the sequence in the mother and the oocyte
should be found in õ3% of Caucasians, making it un-
likely that the result from oocyte 1 is caused by contami-
nation by ‘‘foreign’’ mtDNA.
To further exclude maternal or other contamination,
X-chromosome short-tandem-repeat mapping was per-
formed on the intron 45 short tandem (CA)n repeat of
the X chromosome–encoded Duchenne muscular dys-
trophy gene (Clemens et al. 1991). Both analysis of rele-
vant family members and aliquots of the ﬁrst-round
whole-genome ampliﬁcation PCR of selected mutation-
Figure 2 Oocytes displaying skewed levels of wild-type and mu-
tant mtDNA. Whole-genome ampliﬁcation of total DNA of lysed eggs
from individual III-1 (lanes 1–8), control oocytes (unrelated oocytes
1 and 2), and negative PCR controls was performed simultaneously
in a volume of 50 ml. mtDNA gene-speciﬁc ampliﬁcation and quantita-
tion of the nt 8993 (TrG) mutation utilized 1/25th of the whole-
genome PCR in a standard second-round PCR with the mtDNA-spe-
ciﬁc primer set 8961F and 9050R, followed by HpaII digestion. The
nt 8993 (TrG) mutation introduces a HpaII restriction site, so the
expected digestion products are 89 bp (wild-type and uncut mtDNA)
or 57 and 32 bp (nt 8993 [TrG] mutation present). The percentage
of mutant mtDNA also is indicated. Lanes P-Bl, pri-1, and pri-2 show
results in negative controls: P-Bl Å pronase solution ampliﬁed in the
presence of primers in both rounds of PCR; pri-1 Å no-DNA/primers-
only sample ampliﬁed in both rounds of PCR; and pri-2 Å second-
round mtDNA-speciﬁc PCR no-DNA/primers-only sample.
lent to that of a human oocyte. The four DNA samples
(A–D) contained 0%, 19%, 30%, and 89% mutant
mtDNA, as determined by direct gene-speciﬁc PCR anal-
ysis of 20 ng of DNA. Six independent whole-genome
ampliﬁcations of 350, 35, 3.5, and 0.35 pg of DNA of
Figure 3 mtDNA ampliﬁcation shown to be not variant speciﬁc.each sample, followed by radioactive gene-speciﬁc PCR
Aliquots (2 ml total) of the ﬁrst-round whole-genome ampliﬁcation of
analysis, gave consistent and reproducible results, simi- indicated oocytes were mixed and ampliﬁed in a second-round
lar to those obtained by the direct analysis of 20 ng of mtDNA gene-speciﬁc PCR with the primer set 8961F and 9050R.
After radioactive PCR, 10-ml aliquots of the PCR reaction were di-DNA (table 1). The most-dilute samples gave the weak-
gested with HpaII. Undigested (A) and digested (B) products wereest signals and, consequently, the poorest signal-to-noise
electrophoresed through a 15% nondenaturing polyacrylamide gel.ratios. Nevertheless, even for samples containing only
PCR products were visualized after autoradiography. Lane 1, Oocyte
0.1% of the mtDNA content of a single oocyte, there 1. Lane 2, Oocyte 2. Lane 3, Oocyte 3. Lane 4, Oocytes 1 and 2.
was equivalent ampliﬁcation of both mtDNA species. Lane 5, Oocytes 1 and 3. Lane 6, No-DNA/primers-only control.
HpaII digestion products are as described in the legend to ﬁgure 2.Thus, preferential ampliﬁcation of a single mtDNA spe-
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Table 1 the number of genomes per mitochondrion falls to an
average of approximately two (Hauswirth and Laipis
Reproducibility of PCR Ampliﬁcations of Lymphocyte mtDNA
1985).
It is striking that we saw only extreme levels of wild-Samplea and DNA Average Mutant Load (SD)b
(pg) (%) type and mutant mtDNA in the oocytes. If there is ran-
dom segregation of mutant and normal mtDNA after a
A (0%): ‘‘bottleneck,’’ the presence of Ç5% wild-type mtDNA
350 1 ({1)
in each oocyte carrying the mutation implies that there35 1 ({0)
must be §20 genomes present at the bottleneck. In this3.5 3 ({1)
.35 5 ({3) case, however, we would expect to ﬁnd some oocytes
B (18%): with intermediate degrees of heteroplasmy. Instead, the
350 16 ({1) skewed mtDNA expression patterns suggest that addi-
35 17 ({5)
tional factors inﬂuence the distribution of normal and3.5 15 ({4)
mutant mtDNA. The simplest model that would explain.35 16 ({6)
C (30%): our data would be a preferential, but not exclusive, am-
350 31 ({3) pliﬁcation of mtDNA in perhaps just one organelle early
35 30 ({4) in oogenesis.
3.5 28 ({2)
Disease-causing mtDNA point mutations are fre-.35 23 ({4)
quently inherited, whereas single deletions of mtDNAD (89%):
350 88 ({2) are rarely inherited and thus appear as spontaneous mu-
35 87 ({6) tations (Shoffner andWallace 1995). Furthermore, there
3.5 85 ({3) is an accumulation of mtDNA deletions and point muta-
.35 83 ({5)
tions in somatic cells with age (Trounce et al. 1989;
Mu¨nscher et al. 1993; Nagley et al. 1993; Shoffner anda Percentages shown in parentheses are the nt 8993 (TrG) mutant
loads, determined by direct gene-speciﬁc PCR analysis of 20 ng DNA Wallace 1995). A mechanism must exist to minimize
(without prior whole-genome ampliﬁcation). inheritance of deleterious mtDNA mutations. Chen et
b Six independent whole-genome ampliﬁcations followed by speciﬁc al. (1995) have suggested that this could be achieved if
PCR ampliﬁcation of the mtDNA nt 8993 region were performed on
mutations did not arise in the female germ line, wereeach of the DNA samples.
actively removed in oocytes, or were only rarely trans-
mitted through the mitochondrial bottleneck. Recently,
Jenuth et al. (1996) have created a heteroplasmic mouse
containing oocytes and of the nonmutant oocyte of III-
model that enabled them to study mtDNA distribution
1 were consistent with the origin of the oocytes. Each
in mature and progenitor oocytes. It was concluded that
oocyte tested had only one of the mother’s X-chromo-
random segregation and a bottleneck of Ç200 mtDNA
some alleles, indicating that there was no contamination
in mouse progenitor oocytes could explain the distribu-
of the oocyte mtDNA by maternal or other DNA (data
tion of two polymorphic mtDNAs in heteroplasmic
not shown).
mice. It is difﬁcult to envisage how such a model could
explain our results and the rapid changes in nt 8993
Discussion
(TrG) mutation load between generations in some hu-
man pedigrees (Tulinius et al. 1995; de Coo et al. 1996).It has not previously been possible to measure levels
of an mtDNA variant in human oocytes. The frequencies Mice may segregate mtDNA variants less rapidly than
humans do.of mtDNA variants in human tissues therefore have been
determined in somatic tissues in which the variant DNA Two factors seem most relevant to the heritability of
mtDNA mutations. First, if a mutation is present in onlyhas been subjected to postfertilization segregation events
and, possibly, tissue-speciﬁc selection. When the for- a small proportion of genomes in the primordial oocyte,
as would be the case with age-associated mutations, thenmula used to calculate mtDNA numbers at the bottle-
neck (Ashley et al. 1989; Howell et al. 1992) is applied preferential transmission of a single genome usually will
prevent transfer to the primary oocyte. Second, thereto the blood mutant loads in our family, it yields an
estimate of 800–4,000, whereas the data from the oo- is the functional consequence of a particular mtDNA
mutation. Studies, at the cellular level, of pathogeniccytes and from the mother’s blood predicts a range of
15–70. The exact number of mitochondrial genomes at mtDNA point mutations suggest that these usually need
to be expressed at a level ú95% in order to show athe time of the bottleneck is unclear. However, during
maturation from the primordial oocyte to the mature biochemical defect (Chomyn et al. 1992; King et al.
1992; Trounce et al. 1994; Shoffner and Wallace 1995).oocyte, which contains Ç100,000 mtDNA, the number
of mitochondrial genomes increases by §50-fold, and These point mutations are unlikely to compromise en-
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